Blake Borgeson
Director · 4 filings · Latest: May 5, 2026
RECURSION PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RXRX | Blake Borgeson | Director | May 5, 2026 | Sale | $3.52 | 30,000 | $105.6K | 6,199,863 | |
RXRX | Borgeson Blake | — | May 5, 2026 | Proposed Sale | $3.52 | 30,000 | $105.6K | — | |
RXRX | Blake Borgeson | Director | Apr 7, 2026 | Sale | $3.10 | 30,000 | $93.0K | 6,229,863 | |
RXRX | Borgeson Blake | — | Apr 7, 2026 | Proposed Sale | $3.10 | 30,000 | $93.0K | — | |
RXRX | Blake Borgeson | Director | Mar 3, 2026 | Sale | $3.46 | 170,000 | $588.2K | 6,259,863 | |
RXRX | Borgeson Blake | — | Mar 3, 2026 | Proposed Sale | $3.46 | 170,000 | $588.2K | — | |
RXRX | Blake Borgeson | Director | Feb 3, 2026 | Sale | $4.20 | 220,000 | $924.0K | 6,429,863 | |
RXRX | Borgeson Blake | — | Feb 3, 2026 | Proposed Sale | $4.20 | 220,000 | $924.0K | — | |
RXRX | Borgeson Blake | — | Jan 6, 2026 | Proposed Sale | $4.36 | 220,000 | $959.2K | — | |
RXRX | Borgeson Blake | — | Dec 2, 2025 | Proposed Sale | $4.37 | 220,000 | $961.4K | — | |
RXRX | Borgeson Blake | — | Nov 12, 2024 | Proposed Sale | $7.64 | 11,447 | $87.5K | — | |
RXRX | Borgeson Blake | — | Oct 29, 2024 | Proposed Sale | $6.72 | 11,447 | $76.9K | — | |
RXRX | Borgeson Blake | — | Oct 15, 2024 | Proposed Sale | $6.67 | 11,447 | $76.3K | — | |
RXRX | Borgeson Blake | — | Oct 1, 2024 | Proposed Sale | $6.51 | 11,447 | $74.5K | — | |
RXRX | Borgeson Blake | — | Sep 17, 2024 | Proposed Sale | $6.84 | 11,447 | $78.3K | — | |
RXRX | Borgeson Blake | — | Sep 3, 2024 | Proposed Sale | $6.27 | 11,447 | $71.7K | — |